Semaglutide hub
Microdose semaglutide: definitions, evidence, cost, and providers
Separating approved-semaglutide evidence from compounded low-dose marketing.
Microdose semaglutide means using semaglutide below its labeled maintenance dose. Semaglutide is a single GLP-1 receptor agonist. Its weight-management evidence comes chiefly from the STEP program (e.g., STEP 1 and the STEP 4 maintenance-withdrawal design). This hub separates that approved-product evidence from compounded low-dose marketing, covers the approved-oral vs compounded-oral distinction, and links to cost, providers, safety, and research. Compounded semaglutide is not FDA approved.
Approved semaglutide products
Semaglutide is the active ingredient in Wegovy and Ozempic (both injectable) and Rybelsus (an FDA-approved oral tablet). Rybelsus is the only approved oral semaglutide and is a specific manufactured product — it is not the same as a compounded 'oral semaglutide' drop or troche.
Because an approved oral semaglutide exists, the compounded-oral story here is especially prone to confusion: a compounded sublingual or ODT semaglutide is not Rybelsus and does not inherit its evidence.
The trials behind semaglutide
- STEP 1: weight loss at 2.4 mg weekly vs placebo.
- STEP 4: continued 2.4 mg vs switch-to-placebo after a run-in — the maintenance/withdrawal signal.
What the evidence shows
- Semaglutide's dose-response is established for the approved product in its pivotal program.
- STEP 4 shows weight is largely maintained on continued semaglutide and regained after switching to placebo.
What the evidence does not show
- That a compounded sub-therapeutic 'semaglutide microdose' reproduces those trial results.
- That a compounded sublingual/ODT semaglutide behaves like approved oral Rybelsus.
Ingredient identity & verification
Compounded semaglutide has drawn specific FDA attention over salt forms (semaglutide sodium/acetate), which are not the same active ingredient as the approved base — a reason to verify ingredient identity. See pharmacy verification and semaglutide salt forms.
Explore
- Complete semaglutide microdosing guide
- Cost · providers · evidence review
- Oral & sublingual · injectable
- Maintenance · vs microdose tirzepatide
Frequently asked questions
Is microdose semaglutide FDA approved?
No. There is no FDA-approved 'semaglutide microdose'. Compounded low-dose semaglutide is not FDA approved.
Is compounded oral semaglutide the same as Rybelsus?
No. Rybelsus is a specific approved tablet; a compounded sublingual or ODT semaglutide is a different, non-approved product.
Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.